Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Pozzetti

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Archiv Der Pharmazie|October 9, 2024
Pentathiepins are an understudied molecular prism of biological activitiesLuca Pozzetti, Christopher R M Asquith
European Journal of Medicinal Chemistry|March 2, 2025
Medicinal chemistry applications of the Dimroth Rearrangement to the synthesis of biologically active compoundsLuca Pozzetti, Maja M Pinhammer, Christopher R M Asquith
Nature Reviews. Drug Discovery|February 18, 2026
PIP4K2C: an emerging fulcrum for multiple diseasesLuca Pozzetti, Manjari Mishra, Shirit Einav, et al.
Nature Reviews. Drug Discovery|October 17, 2024
TLK2: a target for cancer and viral latencyLuca Pozzetti, Michael P East, Tuomo Laitinen, et al.
Journal of Medicinal Chemistry|August 27, 2020
Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and AntagonistsStefano Federico, Luca Pozzetti, Alessandro Papa, et al.
Molecules (Basel, Switzerland)|January 21, 2022
Total Synthesis of the Natural Chalcone Lophirone E, Synthetic Studies toward Benzofuran and Indole-Based Analogues, and Investigation of Anti-Leishmanial ActivityLuca Pozzetti, Roberta Ibba, Sara Rossi, et al.
The Journal of Biological Chemistry|August 15, 2022
Crystal structures of Schistosoma mansoni histone deacetylase 8 reveal a novel binding site for allosteric inhibitorsFulvio Saccoccia, Luca Pozzetti, Roberto Gimmelli, et al.
Archiv Der Pharmazie|September 26, 2023
Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agentsAlessandro Papa, Ilaria Cursaro, Luca Pozzetti, et al.
International Journal of Molecular Sciences|October 21, 2020
Setup and Validation of a Reliable Docking Protocol for the Development of Neuroprotective Agents by Targeting the Sigma-1 Receptor (S1R)Giacomo Rossino, Marta Rui, Luca Pozzetti, et al.
ACS Medicinal Chemistry Letters|May 14, 2025
Discovery of <i>p</i>-Trifluoromethylbenzohydrazide Derivatives as Potent Antiviral Agents against Monkeypox VirusSara Rossi, Luca Pozzetti, Gabriele Carullo, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Archiv Der Pharmazie|October 9, 2024
Pentathiepins are an understudied molecular prism of biological activitiesLuca Pozzetti, Christopher R M Asquith
European Journal of Medicinal Chemistry|March 2, 2025
Medicinal chemistry applications of the Dimroth Rearrangement to the synthesis of biologically active compoundsLuca Pozzetti, Maja M Pinhammer, Christopher R M Asquith
Nature Reviews. Drug Discovery|February 18, 2026
PIP4K2C: an emerging fulcrum for multiple diseasesLuca Pozzetti, Manjari Mishra, Shirit Einav, et al.
Nature Reviews. Drug Discovery|October 17, 2024
TLK2: a target for cancer and viral latencyLuca Pozzetti, Michael P East, Tuomo Laitinen, et al.
Journal of Medicinal Chemistry|August 27, 2020
Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and AntagonistsStefano Federico, Luca Pozzetti, Alessandro Papa, et al.
Molecules (Basel, Switzerland)|January 21, 2022
Total Synthesis of the Natural Chalcone Lophirone E, Synthetic Studies toward Benzofuran and Indole-Based Analogues, and Investigation of Anti-Leishmanial ActivityLuca Pozzetti, Roberta Ibba, Sara Rossi, et al.
The Journal of Biological Chemistry|August 15, 2022
Crystal structures of Schistosoma mansoni histone deacetylase 8 reveal a novel binding site for allosteric inhibitorsFulvio Saccoccia, Luca Pozzetti, Roberto Gimmelli, et al.
Archiv Der Pharmazie|September 26, 2023
Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agentsAlessandro Papa, Ilaria Cursaro, Luca Pozzetti, et al.
International Journal of Molecular Sciences|October 21, 2020
Setup and Validation of a Reliable Docking Protocol for the Development of Neuroprotective Agents by Targeting the Sigma-1 Receptor (S1R)Giacomo Rossino, Marta Rui, Luca Pozzetti, et al.
ACS Medicinal Chemistry Letters|May 14, 2025
Discovery of <i>p</i>-Trifluoromethylbenzohydrazide Derivatives as Potent Antiviral Agents against Monkeypox VirusSara Rossi, Luca Pozzetti, Gabriele Carullo, et al.
Pageof 2